J. B. Chemicals & Pharmaceuticals Limited

NSE JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited EPS (Diluted) for the year ending March 31, 2024: USD 0.42

J. B. Chemicals & Pharmaceuticals Limited EPS (Diluted) is USD 0.42 for the year ending March 31, 2024, a 31.22% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

J. B. Chemicals & Pharmaceuticals Limited EPS (Diluted) for the year ending March 31, 2023 was USD 0.32, a -2.94% change year over year.
J. B. Chemicals & Pharmaceuticals Limited EPS (Diluted) for the year ending March 31, 2022 was USD 0.33, a -17.11% change year over year.
J. B. Chemicals & Pharmaceuticals Limited EPS (Diluted) for the year ending March 31, 2021 was USD 0.40, a 74.42% change year over year.
J. B. Chemicals & Pharmaceuticals Limited EPS (Diluted) for the year ending March 31, 2020 was USD 0.23, a -33.01% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

NSE: JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

CEO	Mr. Nikhil Ashokkumar Chopra
IPO Date	July 1, 2002
Location	India
Headquarters	Cnergy IT Park
Employees	5,311
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Cosmetics Dental Care Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Personal Care

Description

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India.

Key trends

Past 5 years